Improving antibacterial prescribing safety in the management of COPD exacerbations: Systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients

Abstract

DDIs related to ABs with clinical significance may involve a wide range of indicated drugs to treat comorbidities in COPD. The evidence presented can support (computer-supported) decision-making by health practitioners when prescribing ABs during COPD exacerbations in the case of co-medication.

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint